Princeton, NJ, United States of America

Tarek A Samad

This inventor holds 23 USPTO granted patents and 5 published patent applications and 3 EPO patents, primarily in Biotechnology. Top assignees: The General Hospital Corporation, Pfizer Corporation. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tarek A Samad. Retrieved from https://idiyas.com/inventor/tarek-a-samad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 69.6

 

Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 196(Granted Patents)


Location History:

  • Gullford, CT (US) (2011 - 2012)
  • Princeton, NJ (US) (2008 - 2014)
  • Guilford, CT (US) (2014)
  • Charlestown, MA (US) (2010 - 2018)
  • Chestnut Hill, MA (US) (2014 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrrolo[2,3-d]pyrimidine Derivatives
Hemojuvelin Fusion Proteins
DRG11-Responsive Proteins
Nucleic Acids
Antibodies
BMP/GDF Signaling
Iron Metabolism
Chimeric Polypeptides
Gene Family
Regulation
Polypeptides
Modulators
23 patents (USPTO):Explore Patents

Title: Tarek A. Samad: Innovator in Pharmaceutical Patents

Introduction

Tarek A. Samad is a prominent inventor based in Princeton, NJ, recognized for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 23 patents, he is actively shaping advancements in medical treatments, particularly in the realm of Janus Kinase (JAK) inhibitors and iron-related disorders.

Latest Patents

Among his latest contributions are the patents for pyrrolo[2,3-d]pyrimidine derivatives, which serve as JAK inhibitors. These compounds have therapeutic implications, particularly in inflammatory conditions. Another recent invention involves nucleic acids that encode hemojuvelin fusion proteins, enabling innovative treatments for iron-related disorders. This patent outlines the applications of a human HJV.Fc protein and methods for producing such proteins. Together, these patents highlight Samad's role in pushing the boundaries of pharmaceutical science.

Career Highlights

Samad has garnered valuable experience through his work with esteemed organizations like The General Hospital Corporation and Pfizer Corporation. His tenure in these leading companies has provided him with a strong foundation to innovate and contribute significantly to the field of pharmaceuticals.

Collaborations

Collaboration has played a vital role in Samad's career. He has worked alongside notable professionals such as Clifford J. Woolf and Herbert Y. Lin. These partnerships underscore the importance of teamwork in fostering innovation and driving forward the development of new therapeutic solutions.

Conclusion

In conclusion, Tarek A. Samad stands out as a prolific inventor in pharmaceuticals with a rich history of innovations and collaborations. His patents not only demonstrate his expertise but also reflect his commitment to advancing medicine through groundbreaking research and development. Samad’s contributions are poised to make a lasting impact on the industry and help improve patient outcomes worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…